Marcial: Is Eli Lilly Ripe for a Rebound?

[guest]

The stock has been battered by worries about generic competition for key compounds. But bulls think drugs under development could provide a much needed lift


More...

Toggle signature
||||| Mentor Group Access Now! |||||